Valdemiro Novela
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Valdemiro Novela has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
- Javier Gandasegui
Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth, Barcelona, Spain
6 shared publications - Lisette van Lieshout
Leiden University Center for Infectious Diseases Subdepartment Research, Leiden University Medical Center, Leiden, Netherlands
5 shared publications - Stephen R. Doyle
Wellcome Sanger Institute
5 shared publications - Alejandro Javier Krolewiecki
Affiliations Fundación Mundo Sano, Madrid, Spain, Instituto de Investigaciones de Enfermedades Tropicales (IIET), Universidad Nacional de Salta, Orán, Salta, Argentina
4 shared publications - Berta Grau-Pujol
ECDC Fellowship Programme, Field Epidemiology path (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
4 shared publications Charfudin Sacoor
Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique
4 shared publications
Latest Publications
- Open Access
Soil-transmitted helminth reinfection after anthelmintic treatment in schools with improved versus unimproved WASH infrastructure in Mozambique: a prospective cohort study
Background: Soil-transmitted helminths (STH) infect more than a billion people worldwide, disproportionately affecting communities with poor water, sanitation, and hygiene (WASH). Mass drug administration is the primary control strategy, but reinfection frequently occurs within months of treatment, and the extent to which improved WASH reduces reinfection risk remains unclear. We conducted a prospective cohort study comparing STH reinfection rates over seven months after anthelmintic treatment among school-aged children attending schools with improved versus unimproved WASH in the Manhiça district, Mozambique, using reinfection dynamics as a proxy for the impact of WASH interventions. Methods: Children were screened for STH using Kato-Katz microscopy, then dewormed with albendazole and praziquantel (plus ivermectin for those positive for T. trichiura and/or S. stercoralis ). A follow-up sample was collected 21 days post-treatment from initially positive children to assess the cure rate (CR) and egg reduction rate (ERR). Cured participants were enrolled in the WASH-improved or WASH-unimproved cohort and followed monthly for seven months. Reinfection and incidence rates were estimated, and Cox proportional hazards regression was used to assess the association between WASH cohort and time to reinfection. Results: STH prevalence was 17.5% (95% CI: 15.2–19.8; n =178/1018), comprising T. trichiura (9.5%), A. lumbricoides (6.3%), S. stercoralis (2.6%), and hookworms (1.9%). No heavy-intensity infections were observed; most T. trichiura (94.9%) and hookworm (94.7%) infections were light, whereas 43.8% of A. lumbricoides infections were moderate. CR/ERR were 88.4%/96.56% for T. trichiura (n=95) and 93.3%/93.36% for A. lumbricoides (n=50). Overall reinfection rate was 32.3% (n=54/167), higher in the improved-WASH cohort (39.3%) than in the unimproved-WASH cohort (18.2%), corresponding to 66.38 reinfections per 1,000 person-months at risk overall (82.27 vs. 35.89 by cohort). The unimproved-WASH cohort had a lower hazard of reinfection (HR=0.456; 95% CI: 0.229–0.908; p =0.0254). Conclusions: Despite effective treatment, over a third of children were reinfected within seven months, with reinfection unexpectedly higher in the improved-WASH cohort. This suggests that infrastructure-based WASH classification may not capture true exposure or behavioural risk, underscoring the need for household-level monitoring to assess WASH impact alongside MDA. Clinical trial number: not applicable.
Open AccessSoil-transmitted helminth reinfection after anthelmintic treatment in schools with improved versus unimproved WASH infrastructure in Mozambique: a prospective cohort study
Background: Soil-transmitted helminths (STH) infect more than a billion people worldwide, disproportionately affecting communities with poor water, sanitation, and hygiene (WASH). Mass drug administration is the primary control strategy, but reinfection frequently occurs within months of treatment, and the extent to which improved WASH reduces reinfection risk remains unclear. We conducted a prospective cohort study comparing STH reinfection rates over seven months after anthelmintic treatment among school-aged children attending schools with improved versus unimproved WASH in the Manhiça district, Mozambique, using reinfection dynamics as a proxy for the impact of WASH interventions. Methods: Children were screened for STH using Kato-Katz microscopy, then dewormed with albendazole and praziquantel (plus ivermectin for those positive for T. trichiura and/or S. stercoralis ). A follow-up sample was collected 21 days post-treatment from initially positive children to assess the cure rate (CR) and egg reduction rate (ERR). Cured participants were enrolled in the WASH-improved or WASH-unimproved cohort and followed monthly for seven months. Reinfection and incidence rates were estimated, and Cox proportional hazards regression was used to assess the association between WASH cohort and time to reinfection. Results: STH prevalence was 17.5% (95% CI: 15.2–19.8; n =178/1018), comprising T. trichiura (9.5%), A. lumbricoides (6.3%), S. stercoralis (2.6%), and hookworms (1.9%). No heavy-intensity infections were observed; most T. trichiura (94.9%) and hookworm (94.7%) infections were light, whereas 43.8% of A. lumbricoides infections were moderate. CR/ERR were 88.4%/96.56% for T. trichiura (n=95) and 93.3%/93.36% for A. lumbricoides (n=50). Overall reinfection rate was 32.3% (n=54/167), higher in the improved-WASH cohort (39.3%) than in the unimproved-WASH cohort (18.2%), corresponding to 66.38 reinfections per 1,000 person-months at risk overall (82.27 vs. 35.89 by cohort). The unimproved-WASH cohort had a lower hazard of reinfection (HR=0.456; 95% CI: 0.229–0.908; p =0.0254). Conclusions: Despite effective treatment, over a third of children were reinfected within seven months, with reinfection unexpectedly higher in the improved-WASH cohort. This suggests that infrastructure-based WASH classification may not capture true exposure or behavioural risk, underscoring the need for household-level monitoring to assess WASH impact alongside MDA. Clinical trial number: not applicable.
- 15 July 2025
- Published by Elsevier in Acta Tropica
- Vol. 269, 107742
Individual-level analysis of the efficacy of albendazole and albendazole-ivermectin fixed-dose coformulation (FDC) against Trichuris trichiura and hookworms
- 15 July 2025
- Published by Elsevier in Acta Tropica
- Vol. 269, 107742
Individual-level analysis of the efficacy of albendazole and albendazole-ivermectin fixed-dose coformulation (FDC) against Trichuris trichiura and hookworms
- Open Access
- 10 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Global diversity of soil-transmitted helminths reveals population-biased genetic variation that impacts diagnostic targets
Soil-transmitted helminths (STHs) are intestinal parasites that affect over a billion people worldwide. STH control relies on microscopy-based diagnostics to monitor parasite prevalence and enable post-treatment surveillance; however, molecular diagnostics are rapidly being developed due to increased sensitivity, particularly in low-STH-prevalence settings. The genetic diversity of helminths and its potential impact on molecular diagnostics remain unclear. Using low-coverage genome sequencing, we assess the genetics of STHs within worm, faecal, and purified egg samples from 27 countries, identifying differences in the genetic connectivity and diversity of STH-positive samples across regions and cryptic diversity between closely related human- and pig-infective species. We define substantial copy number and sequence variants in current diagnostic target regions and validate the impact of genetic variation on qPCR diagnostics using in vitro assays. Our study provides insights into the diversity and genomic epidemiology of STHs, highlighting both the challenges and opportunities for developing molecular diagnostics needed to support STH control efforts.
- 10 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Open AccessGlobal diversity of soil-transmitted helminths reveals population-biased genetic variation that impacts diagnostic targets
Soil-transmitted helminths (STHs) are intestinal parasites that affect over a billion people worldwide. STH control relies on microscopy-based diagnostics to monitor parasite prevalence and enable post-treatment surveillance; however, molecular diagnostics are rapidly being developed due to increased sensitivity, particularly in low-STH-prevalence settings. The genetic diversity of helminths and its potential impact on molecular diagnostics remain unclear. Using low-coverage genome sequencing, we assess the genetics of STHs within worm, faecal, and purified egg samples from 27 countries, identifying differences in the genetic connectivity and diversity of STH-positive samples across regions and cryptic diversity between closely related human- and pig-infective species. We define substantial copy number and sequence variants in current diagnostic target regions and validate the impact of genetic variation on qPCR diagnostics using in vitro assays. Our study provides insights into the diversity and genomic epidemiology of STHs, highlighting both the challenges and opportunities for developing molecular diagnostics needed to support STH control efforts.
- Open Access
- 20 December 2024
- Published by Springer Nature in Parasites & Vectors
- Vol. 17 (1) , 525
Correction: Baseline gut microbiota diversity and composition and albendazole efficacy in hookworm-infected individuals
- 20 December 2024
- Published by Springer Nature in Parasites & Vectors
- Vol. 17 (1) , 525
Open AccessCorrection: Baseline gut microbiota diversity and composition and albendazole efficacy in hookworm-infected individuals
- Open Access
- 12 November 2024
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 26, 100570
Deep-amplicon sequencing of the complete beta-tubulin gene in Trichuris trichiura before and after albendazole treatment
- 12 November 2024
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 26, 100570
Open AccessDeep-amplicon sequencing of the complete beta-tubulin gene in Trichuris trichiura before and after albendazole treatment
- Open Access
Global diversity of soil-transmitted helminths reveals population-biased genetic variation that impacts diagnostic targets
Soil-transmitted helminths (STHs) are intestinal pathogens affecting over a billion people worldwide. STH control relies on microsopy-based diagnostics to monitor parasite prevalence and enable post-treatment surveillance, however, molecular diagnostics are rapidly being developed due to increased sensitivity, particularly in low-STH-prevalence settings. The genetic diversity of helminths and its potential impact on molecular diagnostics remains unclear. Using low-coverage genome sequencing, we assessed the presence of STHs in worm, faecal and purified egg samples from 27 countries, identifying differences in the genetic connectivity and diversity of STH-positive samples across regions and cryptic diversity between closely related human- and pig-infective species. We defined substancial copy number and sequence variants in current diagnostic targets and validated the impact of genetic variants on qPCR diagnostics using in vitro assays. Our study provides insights into the diversity and genomic epidemiology of STHs, highlighting challenges and opportunities for developing molecular diagnostics needed to support STH control efforts.
Open AccessGlobal diversity of soil-transmitted helminths reveals population-biased genetic variation that impacts diagnostic targets
Soil-transmitted helminths (STHs) are intestinal pathogens affecting over a billion people worldwide. STH control relies on microsopy-based diagnostics to monitor parasite prevalence and enable post-treatment surveillance, however, molecular diagnostics are rapidly being developed due to increased sensitivity, particularly in low-STH-prevalence settings. The genetic diversity of helminths and its potential impact on molecular diagnostics remains unclear. Using low-coverage genome sequencing, we assessed the presence of STHs in worm, faecal and purified egg samples from 27 countries, identifying differences in the genetic connectivity and diversity of STH-positive samples across regions and cryptic diversity between closely related human- and pig-infective species. We defined substancial copy number and sequence variants in current diagnostic targets and validated the impact of genetic variants on qPCR diagnostics using in vitro assays. Our study provides insights into the diversity and genomic epidemiology of STHs, highlighting challenges and opportunities for developing molecular diagnostics needed to support STH control efforts.
- Open Access
- 5 May 2022
- Published by F1000 Research Ltd in Gates Open Research
- Vol. 6, 62
An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
Background: Soil-transmitted helminths (STH) are targeted for control through mass drug-administration campaigns to prevent morbidity affecting at-risk groups in endemic regions. Although broadly successful, the use of albendazole and mebendazole achieved variable progress, with deficiencies against Trichuris trichiura and a predictable low efficacy against Strongyloides stercoralis. Novel drug combinations offer a potential solution, providing they can be delivered safely and maintain efficacy against all STH species. Here we present the protocol of a clinical trial to evaluate a fixed-dose combination (FDC) tablet containing albendazole and ivermectin that will be compared against albendazole against STH. Methods: An adaptive phase II/III randomized controlled trial will be undertaken in STH endemic sites in Ethiopia, Kenya and Mozambique to evaluate an oral FDC of 400 mg albendazole and either 9- or 18 mg ivermectin. FDC will be administered as a single dose or single doses over three-consecutive days and assessed against a single dose of 400 mg albendazole. In the phase II trial, 126 T. trichiura-infected children weighting 15 to 45 kg will be treated in a dose-escalation manner to determine safety objectives. In the phase III trial, 1097 participants aged 5 to 18 years old infected with T. trichiura, hookworm and S. stercoralis will be recruited to determine safety and efficacy. The trial will be open-label with blinded outcome assessors. Cure rate measured 21-days after-treatment in duplicate Kato-Katz is the primary efficacy outcome. Secondary objectives include efficacy evaluation by quantitative polymerase chain reaction (PCR) as an outcome measurement, description of pharmacokinetic parameters, palatability and acceptability evaluations, and monitoring of anthelmintic resistance. Conclusions: This trial with registrational goals seeks to evaluate an innovative fixed-dose combination of albendazole and ivermectin co-formulated tablets, with the goal of providing an anthelmintic regimen with improved efficacy and spectrum of coverage against STH. ClinicalTrials.gov registration: NCT05124691 (18/11/2021).
- 5 May 2022
- Published by F1000 Research Ltd in Gates Open Research
- Vol. 6, 62
Open AccessAn adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
Background: Soil-transmitted helminths (STH) are targeted for control through mass drug-administration campaigns to prevent morbidity affecting at-risk groups in endemic regions. Although broadly successful, the use of albendazole and mebendazole achieved variable progress, with deficiencies against Trichuris trichiura and a predictable low efficacy against Strongyloides stercoralis. Novel drug combinations offer a potential solution, providing they can be delivered safely and maintain efficacy against all STH species. Here we present the protocol of a clinical trial to evaluate a fixed-dose combination (FDC) tablet containing albendazole and ivermectin that will be compared against albendazole against STH. Methods: An adaptive phase II/III randomized controlled trial will be undertaken in STH endemic sites in Ethiopia, Kenya and Mozambique to evaluate an oral FDC of 400 mg albendazole and either 9- or 18 mg ivermectin. FDC will be administered as a single dose or single doses over three-consecutive days and assessed against a single dose of 400 mg albendazole. In the phase II trial, 126 T. trichiura-infected children weighting 15 to 45 kg will be treated in a dose-escalation manner to determine safety objectives. In the phase III trial, 1097 participants aged 5 to 18 years old infected with T. trichiura, hookworm and S. stercoralis will be recruited to determine safety and efficacy. The trial will be open-label with blinded outcome assessors. Cure rate measured 21-days after-treatment in duplicate Kato-Katz is the primary efficacy outcome. Secondary objectives include efficacy evaluation by quantitative polymerase chain reaction (PCR) as an outcome measurement, description of pharmacokinetic parameters, palatability and acceptability evaluations, and monitoring of anthelmintic resistance. Conclusions: This trial with registrational goals seeks to evaluate an innovative fixed-dose combination of albendazole and ivermectin co-formulated tablets, with the goal of providing an anthelmintic regimen with improved efficacy and spectrum of coverage against STH. ClinicalTrials.gov registration: NCT05124691 (18/11/2021).
- Open Access
- 25 October 2021
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 15 (10) , e0009803
Towards soil-transmitted helminths transmission interruption: The impact of diagnostic tools on infection prediction in a low intensity setting in Southern Mozambique
World Health Organization goals against soil-transmitted helminthiases (STH) are pointing towards seeking their elimination as a public health problem: reducing to less than 2% the proportion of moderate and heavy infections. Some regions are reaching WHO goals, but transmission could rebound if strategies are discontinued without an epidemiological evaluation. For that, sensitive diagnostic methods to detect low intensity infections and localization of ongoing transmission are crucial. In this work, we estimated and compared the STH infection as obtained by different diagnostic methods in a low intensity setting. We conducted a cross-sectional study enrolling 792 participants from a district in Mozambique. Two stool samples from two consecutive days were collected from each participant. Samples were analysed by Telemann, Kato-Katz and qPCR for STH detection. We evaluated diagnostic sensitivity using a composite reference standard. By geostatistical methods, we estimated neighbourhood prevalence of at least one STH infection for each diagnostic method. We used environmental, demographical and socioeconomical indicators to account for any existing spatial heterogeneity in infection. qPCR was the most sensitive technique compared to composite reference standard: 92% (CI: 83%– 97%) for A. lumbricoides, 95% (CI: 88%– 98%) for T. trichiura and 95% (CI: 91%– 97%) for hookworm. qPCR also estimated the highest neighbourhood prevalences for at least one STH infection in a low intensity setting. While 10% of the neighbourhoods showed a prevalence above 20% when estimating with single Kato-Katz from one stool and Telemann from one stool, 86% of the neighbourhoods had a prevalence above 20% when estimating with qPCR. In low intensity settings, STH estimated prevalence of infection may be underestimated if based on Kato-Katz. qPCR diagnosis outperformed the microscopy methods. Thus, implementation of qPCR based predictive maps at STH control and elimination programmes would disclose hidden transmission and facilitate targeted interventions for transmission interruption.
- 25 October 2021
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 15 (10) , e0009803
Open AccessTowards soil-transmitted helminths transmission interruption: The impact of diagnostic tools on infection prediction in a low intensity setting in Southern Mozambique
World Health Organization goals against soil-transmitted helminthiases (STH) are pointing towards seeking their elimination as a public health problem: reducing to less than 2% the proportion of moderate and heavy infections. Some regions are reaching WHO goals, but transmission could rebound if strategies are discontinued without an epidemiological evaluation. For that, sensitive diagnostic methods to detect low intensity infections and localization of ongoing transmission are crucial. In this work, we estimated and compared the STH infection as obtained by different diagnostic methods in a low intensity setting. We conducted a cross-sectional study enrolling 792 participants from a district in Mozambique. Two stool samples from two consecutive days were collected from each participant. Samples were analysed by Telemann, Kato-Katz and qPCR for STH detection. We evaluated diagnostic sensitivity using a composite reference standard. By geostatistical methods, we estimated neighbourhood prevalence of at least one STH infection for each diagnostic method. We used environmental, demographical and socioeconomical indicators to account for any existing spatial heterogeneity in infection. qPCR was the most sensitive technique compared to composite reference standard: 92% (CI: 83%– 97%) for A. lumbricoides, 95% (CI: 88%– 98%) for T. trichiura and 95% (CI: 91%– 97%) for hookworm. qPCR also estimated the highest neighbourhood prevalences for at least one STH infection in a low intensity setting. While 10% of the neighbourhoods showed a prevalence above 20% when estimating with single Kato-Katz from one stool and Telemann from one stool, 86% of the neighbourhoods had a prevalence above 20% when estimating with qPCR. In low intensity settings, STH estimated prevalence of infection may be underestimated if based on Kato-Katz. qPCR diagnosis outperformed the microscopy methods. Thus, implementation of qPCR based predictive maps at STH control and elimination programmes would disclose hidden transmission and facilitate targeted interventions for transmission interruption.
- Open Access
Plasmodium falciparum and helminth coinfections increase IgE and parasite-specific IgG responses
Coinfection with Plasmodium falciparum and helminths may impact the immune response to these parasites since they induce different immune profiles. We studied the effects of coinfections on the antibody profile in a cohort of 715 Mozambican children and adults using the Luminex technology with a panel of 16 antigens from P. falciparum and 11 antigens from helminths ( Ascaris lumbricoides , hookworm, Trichuris trichiura , Strongyloides stercoralis and Schistosoma spp.) and measured antigen-specific IgG and total IgE responses. We compared the antibody profile between groups defined by P. falciparum and helminth previous exposure (based on serology) and/or current infection (determined by microscopy and/or qPCR). In multivariable regression models adjusted by demographic, socioeconomic, water and sanitation variables, individuals exposed/infected with P. falciparum and helminths had significantly higher total IgE and antigen-specific IgG levels, magnitude (sum of all levels) and breadth of response to both types of parasites compared to individuals exposed/infected with only one type of parasite (p≤ 0.05). There was a positive association between exposure/infection to P. falciparum and exposure/infection to helminths or the number of helminth species, and vice versa (p≤ 0.001). In addition, children coexposed/coinfected tended (p= 0.062) to have higher P. falciparum parasitemia than those single exposed/infected. Our results suggest that an increase in the antibody responses in coexposed/coinfected individuals may reflect higher exposure and be due to a more permissive immune environment to infection in the host. GRAPHICAL
Open AccessPlasmodium falciparum and helminth coinfections increase IgE and parasite-specific IgG responses
Coinfection with Plasmodium falciparum and helminths may impact the immune response to these parasites since they induce different immune profiles. We studied the effects of coinfections on the antibody profile in a cohort of 715 Mozambican children and adults using the Luminex technology with a panel of 16 antigens from P. falciparum and 11 antigens from helminths ( Ascaris lumbricoides , hookworm, Trichuris trichiura , Strongyloides stercoralis and Schistosoma spp.) and measured antigen-specific IgG and total IgE responses. We compared the antibody profile between groups defined by P. falciparum and helminth previous exposure (based on serology) and/or current infection (determined by microscopy and/or qPCR). In multivariable regression models adjusted by demographic, socioeconomic, water and sanitation variables, individuals exposed/infected with P. falciparum and helminths had significantly higher total IgE and antigen-specific IgG levels, magnitude (sum of all levels) and breadth of response to both types of parasites compared to individuals exposed/infected with only one type of parasite (p≤ 0.05). There was a positive association between exposure/infection to P. falciparum and exposure/infection to helminths or the number of helminth species, and vice versa (p≤ 0.001). In addition, children coexposed/coinfected tended (p= 0.062) to have higher P. falciparum parasitemia than those single exposed/infected. Our results suggest that an increase in the antibody responses in coexposed/coinfected individuals may reflect higher exposure and be due to a more permissive immune environment to infection in the host. GRAPHICAL